• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Senate committee to vote on Dr. Oz’s nomination to run the Centers for Medicare and Medicaid Services

by March 25, 2025
written by March 25, 2025

The Senate Committee on Finance is set to vote later Tuesday afternoon on whether to advance President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, Dr. Mehmet Oz, to a full Senate confirmation vote. 

The vote follows two hearings by the committee that probed Oz over his plans for the federal healthcare programs, his views on abortion, potential conflicts of interest in the healthcare industry and more.   

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. 

Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services.

Earlier this month, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were also approved in committee and are awaiting full confirmation votes in the Senate. 

Around the same time that Bhattacharya and Makary won committee approval, Trump withdrew his nomination of former Florida Rep. David Weldon to run the CDC, over fears he did not have the GOP support to clear full confirmation. 

On Monday, the Trump administration named Susan Monarez, acting director of the CDC, as its new nominee.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump not planning to fire Waltz after national security text chain leak
next post
Dem senator calls for Waltz, Hegseth to resign as Gabbard says no classified material shared in Signal

related articles

Why a credit freeze isn’t the end of...

February 21, 2026

Trump torches ‘stupid’ AOC’s Munich showing, tees up...

February 21, 2026

DAVID MARCUS: To burnish Trump’s legacy, we need...

February 21, 2026

BROADCAST BIAS: Idea of giving politicians equal time...

February 21, 2026

Israelis keep suitcases packed and ready as Trump...

February 21, 2026

EPA scraps Biden coal restrictions, and advocates say...

February 21, 2026

CIA retracts, revises 19 past intelligence assessments deemed...

February 21, 2026

Trump signs off on 10% global tariff, criticizes...

February 21, 2026

EPA scraps Biden coal restrictions as advocates say...

February 21, 2026

RFK Jr defends Trump move to protect pesticide...

February 20, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Long UK100: bullish momentum fueled by strong corporate earnings and positive market sentiment

    July 31, 2024
  • Brennan directed publication of ‘implausible’ reports claiming Putin preferred Trump in 2016, House found

    July 23, 2025
  • FDA officially authorizes Zyn nicotine pouches for sale following health review

    January 17, 2025
  • Retail panic: What the end of the ‘de minimis’ exemption means for brands across the globe

    August 29, 2025
  • SafeMoon and Litecoin: LItecoin fails to break above $66.00

    July 10, 2024

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,023)
  • Investing (1,019)
  • Stock (979)

Latest Posts

  • Secret Service responds to report they ‘repeatedly’ denied requests to Trump security detail in the past

    July 21, 2024
  • Food stamp benefits for 42 million Americans in jeopardy today amid shutdown

    November 1, 2025
  • Serbian foreign minister proposes hosting Ukraine-Russia peace negotiations amid ongoing conflict

    October 25, 2025

Recent Posts

  • Gabbard says Biden admin ignored ‘highly inappropriate’ chats happening at national security agencies

    February 28, 2025
  • Netanyahu gifts Fetterman a silver-plated beeper after he praised Israel’s Lebanon pager operation

    March 20, 2025
  • Bernie Moreno wants Senate to call for Nobel Peace Prize to go to Trump

    June 25, 2025

Editor’s Pick

  • The 10 worst states to retire in the U.S. No. 1 isn’t California or New York

    July 31, 2024
  • Former Vice President Mike Pence honored by Kennedy family in receiving the JFK ‘Profile in Courage Award’

    May 5, 2025
  • Trump can delete Elizabeth Warren’s failed experiment once and for all

    February 5, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock